Evidence map›Paper›PMID 35628780›Full record

ArticleJournal of fungi (Basel, Switzerland)2022

Synergistic In Vitro Interaction of Isavuconazole and Isoquercitrin against

Petra V Schwarz, Ilya Nikolskiy, Eric Dannaoui, Frank Sommer, Gert Bange, Patrick Schwarz

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of fungi (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Natural product based approaches to overcomeFrontiers in antibiotics · 2026
    Review
  3. Antifungal Drug Susceptibility Profile ofThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Petra V SchwarzCenter for Invasive Mycoses and Antifungals, Faculty of Medicine, Philipps University Marburg, D-35043 Marburg, Germany.
Ilya NikolskiyCenter for Invasive Mycoses and Antifungals, Faculty of Medicine, Philipps University Marburg, D-35043 Marburg, Germany.
Eric DannaouiUnité de Parasitologie-Mycologie, Hôpital Européen Georges-Pompidou, F-75015 Paris, France.ORCID 0000-0002-2817-3830
Frank SommerDepartment of Microbiology, University Hospital Marburg, D-35032 Marburg, Germany.
Gert BangeCenter for Synthetic Microbiology (SYNMIKRO), Department of Chemistry, Philipps University Marburg, D-35043 Marburg, Germany.
Patrick SchwarzCenter for Invasive Mycoses and Antifungals, Faculty of Medicine, Philipps University Marburg, D-35043 Marburg, Germany.ORCID 0000-0003-0383-1865
Philipps University of Marburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In vitro interactions of broad-spectrum azole isavuconazole with flavonoid isoquercitrin were evaluated by a broth microdilution checkerboard technique based on the European Committee on Antimicrobial Susceptibility Testing (EUCAST) reference methodology for antifungal susceptibility testing against 60

Indexed as

antifungal combinationCandidaEUCASTin vitroisavuconazoleisoquercitrin

Identifiers

PMID35628780
PMCPMC9147185
OpenAlexW4282939636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.